AAAnzhela Aslanovna Aleksandrova

Anzhela Aslanovna Aleksandrova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anzhela Aslanovna Aleksandrova has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The involvement of polymorphisms in the MALAT1 and NEAT1 lncRNA genes in PCOS etiology

    by Svetlana Vitalievna Lomteva, Karina Yurievna Sagamonova, Ruba Mohamad Ali, Manar Noor Aldeen Ammar, Sofia Valeryevna Yachneva, Anzhela Aslanovna Aleksandrova

    Background: Hormonal imbalance and metabolic inefficiency are hallmarks of the common complicated endocrine condition known as polycystic ovary syndrome (PCOS). Long non-coding RNAs (lncRNAs) have emerged as critical regulators of gene expression and cellular processes in various diseases, including PCOS. This study aims to investigate the relationship between specific polymorphisms in the lncRNA genes MALAT1 (rs3200401) and NEAT1 (rs674485) and the likelihood of developing PCOS. A case-control study was conducted involving PCOS women and control undergoing in vitro fertilization (IVF) at the Center for Human Reproduction and IVF in Rostov-on-Don, Russia. Genotyping was conducted using an allele-specific real-time PCR approach. Results: Our results suggest a possible association between MALAT1 rs3200401 and increased PCOS risk at the allelic level. While the difference observed in the GA genotype of NEAT1 rs674485 did not reach statistical significance and required confirmation in larger cohorts. In addition, deviation from the Hardy–Weinberg equilibrium was observed in control groups, which may reflect sample size limitations or population-specific effects. Bioinformatic analyses indicated that both variants may potentially influence the lncRNA secondary structure and microRNA binding sites; however, these findings are computational predictions and require experimental validation. Conclusion: These findings underscore the potential of MALAT1 and NEAT1 genetic variants as biomarkers and therapeutic targets in PCOS.

  • Analysis of gene-gene interactions of polymorphic loci of TYK2, miR-146a and miR-155 genes in patients with different severity of COVID-19 coronavirus infection

    by Ekaterina Ivanova, A. A. Aleksandrova, Stanislav Zatonsky, I. S. Dolgushin, Tatiana Shkurat

    журнал Живые и биокосные системы Анализ межгенных взаимодействий полиморфных локусов генов TYK2, miR-146a и miR-155 у пациентов с разной степенью течения коронавирусной инфекции COVID-19

  • Open Access

    Association of superoxide dismutase and catalase genetic variants and their gene-gene interactions with the severity of COVID-19

    by Moez A. Eid, Anzhela A. Aleksandrova, Peter O. Kosenko, Tatiana P. Shkurat, Ид Муэз

    BACKGROUND: Since the outbreak of COVID-19 infection, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), oxidative stress has been proposed as an important player in its severity. This increased the interest in studying antioxidant systems to evaluate their possible role in counteracting disease progression. AIM: The aim of the current study was to investigate the association of single nucleotide polymorphism (SNP) of superoxide dismutase (SOD) and catalase (CAT) genes with the severity of COVID-19. MATERIALS AND METHODS: Study subjects were divided into two groups based on the severity of their symptoms. Allele-specific PCR was used for genotyping, and multifactor dimensionality reduction (MDR) analysis was performed to investigate the SNP–SNP interaction models. RESULTS: The results showed a significant association of SOD2 rs4880 with the severity of COVID-19 (p = 0.002). SOD2 47TT genotype was significantly more frequent among patients with severe COVID-19 (OR 4.34; 95% CI 1.72–10.96). The three-locus SNP–SNP interaction model, resulted from MDR analysis, was statistically significant (0.55 × 10–4, OR 3.81; 95% CI 1.96–7.42). Carriers of SOD1 7958G * SOD2 47T * CAT 262C allele combination had a higher risk of severe COVID-19 (p = 0.0045, OR 2.84, 95% CI 1.40–5.78). CONCLUSIONS: The obtained results contribute to better understanding of COVID-19 pathogenesis and suggest novel potential prognostic biomarkers of the infection.


  • Open Access

    Differential expression of CYP19A1 and lncRNA-CTBP1-AS in the granulosa cells of women with polycystic ovary syndrome

    by Ruba M. Ali, Southern Federal University, Svetlana V. Lomteva, Anzhela A. Aleksandrova, Karina Yu. Sagamonova, Artur S. Sagamonov, Manar N.A. Ammar, Tatiana P. Shkurat, Center For Human Reproduction And Ivf, Nauka, et al.

    Background: Hyperandrogenism is the basic indicator of polycystic ovarian syndrome (PCOS) and a ...


  • Effect of polymorphisms CYP17 (rs743572), SOD2 (rs4880) and CAT (rs1001179) on hormonal profile and redox status of blood serum and follicular fluid in patients with polycystic ovary syndrome

    by Ruba Mohamed Ali, Svetlana Vitalievna Lomteva, Anzhela Aslanovna Aleksandrova, Ludmilla Valeryevna Gutnikova, Elena Sergeevna Bugrimova, Karina Yurievna Sagamonova, Manar Noor Aldeen Ammar, Tatiana Pavlovna Shkurat


  • Open Access

    Violation of the Hormonal Spectrum in Polycystic Ovaries in Combination with Insulin Resistance. What is the Trigger: Insulin Resistance or Polycystic Ovary Disease?

    by Lomteva S V, Shkurat T P, Bugrimova E S, Zolotykh O S, Alexandrova A A, Karantysh G V

    Polycystic ovary syndrome (PCOS) is the main cause of female infertility. The role of insulin resistance in the development of polycystic ovary is actively discussed here. The study included patients with PCOS without insulin resistance (n = 48) and with insulin resistance (n = 39). The comparison groups were patients with no history of PCOS: a control group without insulin resistance (n = 46) and a group of patients with insulin resistance (n = 45). The following parameters were determined in patients: FSH, LH, TSH, T3f, T4f, PRL, E2, 17-OHd, Pr, AMH, Test total, Testf, DHEAS, DHEASs, SHBG, ACTH, cortisol, IRI, IGF-1, C-peptide, and glucose level. The HOMA-IR index and the LH / FSH ratio and the total / SHBG test were calculated. Correlation analysis was also performed between HOMA IR and indicators of the hormonal profile, IGF-1, and C-peptide.Unidirectional changes in the levels of the following hormones were found in insulin resistance, PCOS and / or insulin resistance relative to control values: estradiol, total testosterone, cortisol, prolactin, AMG, and SHBG. As a result of the correlation analysis, negative relationships were established between the HOMA IR Index and the levels of E2, cortisol and AMH in patients (except for the control group).We assume that the formation of the phenotype of polycystic ovary with a combination of insulin resistance can be formed in patients with insulin resistance as a result of a decrease in the level of estradiol, SHBG and an increase in the content of total testosterone and AMH.


  • Oxidative status shifts in uterine cervical incompetence patients

    by Petr Zolotukhin, Anzhela Aleksandrova, Anna Goncharova, Aleksandr Shestopalov, Aleksandr Rymashevskiy, Tatyana Shkurat

    Uterine cervical incompetence (UCI) is a pregnancy complication affecting about 10% of the pregnancies in the western world. Studying the etiology of the UCI requires a specific approach adequate for this highly heterogenous syndrome. Oxidative status disorders are associated with various pathologies, including pregnancy complications. As such, general oxidative status profiling is a promising methodology to treat UCI. We aimed at assaying the closely interrelated oxidative status markers in the uterine cervical incompetence patients by means of the systems biology-oriented approach. Chemiluminescent assay, circulating thioredoxin 1 protein, uric acid, and homocysteine level measurements were used to assess the character of the oxidative status regulation in the UCI patients. We found UCI to be associated with the atypical plasma oxidative status deregulation; UCI plasma samples demonstrated lowered proneness to the pro-oxidative processes, and this was not due to the excessive antioxidant activity. There were neither signs of oxidative stress nor destructive pro-oxidant feedforward circuit locking in the UCI group. We also report increased circulating levels of uric acid in the UCI patients.